Picture of Paul Hartmann AG logo

PHH2 Paul Hartmann AG Share Price

0.000.00%
de flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Momentum

Relative Strength (%)
1m-0.33%
3m-1.25%
6m-4.98%
1yr-16.24%
Volume Change (%)
10d/3m+44.62%
Price vs... (%)
52w High-15.16%
50d MA-4.6%
200d MA+0.34%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital4.18%
Return on Equity2.65%
Operating Margin2.66%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total Revenue€m2,186.762,433.042,301.772,311.612,353.26n/an/a2.12%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-27.38+145.59-31.41-47.67-0.31n/an/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Paul Hartmann AG EPS forecast chart

Profile Summary

Paul Hartmann AG is a Germany-based holding company that is principally engaged in the field of medical and healthcare products. The Company operates through four segments, namely Wound Management, Incontinence Management, Infection Management and Other Group Activities. The Wound Management segment comprises wound dressings, as well as products for compression treatment, immobilization, First Aid and diagnostic devices. The Incontinence Management segment includes absorbent products worn close to the body for incontinence hygiene, such as under pads for patients as well as patient hygiene products and medical skin care. The Infection Management segment covers a range of custom procedure trays, surgical draping systems, surgical clothing, and surgical and examination gloves as well as the disinfection assortment. The Other Group Activities includes activities in cotton-wool products, feminine hygiene, baby care, medical consumer goods and pharmaceutical products, among others.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
December 11th, 1912
Public Since
January 1st, 2003
No. of Employees
10,168
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
de flag iconFrankfurt Stock Exchange
Shares in Issue
3,551,742

PHH2 Share Price Performance

Upcoming Events for PHH2

Paul Hartmann AG Annual Shareholders Meeting

Dividend For PHHGn.F - 8.0000 EUR

Q1 2024 Paul Hartmann AG Earnings Release

Q2 2024 Paul Hartmann AG Earnings Release

Similar to PHH2

Picture of elexxion AG logo

elexxion AG

de flag iconFrankfurt Stock Exchange

Picture of Sartorius AG logo

Sartorius AG

de flag iconFrankfurt Stock Exchange

Picture of Sartorius AG logo

Sartorius AG

de flag iconFrankfurt Stock Exchange

Picture of SCHOTT Pharma AG & Co KgaA logo

SCHOTT Pharma AG & Co KgaA

de flag iconFrankfurt Stock Exchange

Picture of Veeva Systems logo

Veeva Systems

de flag iconFrankfurt Stock Exchange

FAQ